Tovinontrine

N/A

Report date: 2024/04/11 14:26:21
NME

Base Information

Drug NameTovinontrine
Drug Alias NameIMR-687AF6872268722CK1598CRD-750
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPhosphodiesterase 9A inhibitors
TargetsPhosphodiesterase 9A
Therapy Area/Indicationsbeta-ThalassemiaHemoglobin SC DiseaseAnemia, Sickle Cell +[8
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBelgiumBulgaria +[33
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesH. Lundbeck A/S
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsAnemia, Sickle CellHeart Failure, SystolicHeart Failure, Diastolic +[5
Inactive Indicationsbeta-ThalassemiaHemoglobin SC DiseaseCardiovascular Diseases

Other Information

ATC CodeN/A
Related LinksDrugBankKEGG